BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11365949)

  • 1. Cost of managed HIV care remains stable, study says.
    AIDS Policy Law; 1998 Oct; 13(19):15. PubMed ID: 11365949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs of care for HIV infection in a managed care population from 1995 to 1997.
    Lapins DL; Urdaneta ME; Barrett J; Hamel EC; Duong PT; Markson LE
    Am J Manag Care; 2000 Sep; 6(9):973-81. PubMed ID: 11184068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Providing antiretroviral therapy for HIV infection.
    Steinbrook R
    N Engl J Med; 2001 Mar; 344(11):844-6. PubMed ID: 11248164
    [No Abstract]   [Full Text] [Related]  

  • 4. New study shows average per patient cost of HIV care in managed care setting stabilized in 1997.
    J Assoc Nurses AIDS Care; 1999; 10(1):79. PubMed ID: 9934674
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost of medical care, once falling, may be starting to rise again.
    AIDS Policy Law; 1999 Oct; 14(20):5. PubMed ID: 11367061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The changing direct costs of medical care for patients with HIV/AIDS, 1995-2001.
    Krentz HB; Auld MC; Gill MJ;
    CMAJ; 2003 Jul; 169(2):106-10. PubMed ID: 12874156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined antiviral treatment in HIV infection. Is it value for money?
    Davies D; Carne C; Camilleri-Ferrante C
    Public Health; 1999 Nov; 113(6):315-7. PubMed ID: 10637527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal analysis of healthcare costs after treatment optimization following genotypic antiretroviral resistance testing: does resistance testing pay off?
    Simcock M; Sendi P; Ledergerber B; Keller T; Schüpbach J; Battegay M; Günthard HF;
    Antivir Ther; 2006; 11(3):305-14. PubMed ID: 16759046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing total health care costs and treatment patterns of HIV patients in a managed care setting.
    Purdum AG; Johnson KA; Globe DR
    AIDS Care; 2004 Aug; 16(6):767-80. PubMed ID: 15370064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs associated with combination antiretroviral therapy in HIV-infected patients.
    Yazdanpanah Y
    J Antimicrob Chemother; 2004 Apr; 53(4):558-61. PubMed ID: 14985277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggressive HIV treatment cost-effective.
    Healthc Benchmarks; 1998 Aug; 5(8):128-9. PubMed ID: 10182003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIDS costs remain problematic despite improvements in therapy.
    Capitation Rates Data; 1998 Sep; 3(9):101-3. PubMed ID: 10621187
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment. Antiretroviral adherence results in lower health care costs, study says.
    AIDS Policy Law; 2010 Feb; 25(3):1. PubMed ID: 20419883
    [No Abstract]   [Full Text] [Related]  

  • 14. Modeling the use of triple combination therapy in five countries: nevirapine, Zidovudine, and Didanosine.
    Biddle AK; Simpson KN
    Value Health; 2000; 3(3):186-201. PubMed ID: 16464183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managed care and HIV.
    Soloway B; Hecht FM
    AIDS Clin Care; 1997 Sep; 9(9):67-9, 71. PubMed ID: 11364754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economics of effective AIDS treatment in Thailand.
    Over M; Revenga A; Masaki E; Peerapatanapokin W; Gold J; Tangcharoensathien V; Thanprasertsuk S
    AIDS; 2007 Jul; 21 Suppl 4():S105-16. PubMed ID: 17620745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The costs and benefits of private sector provision of treatment to HIV-infected employees in Kampala, Uganda.
    Marseille E; Saba J; Muyingo S; Kahn JG
    AIDS; 2006 Apr; 20(6):907-14. PubMed ID: 16549976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care quality versus economics in HIV.
    Torres G
    GMHC Treat Issues; 1996; 10(6/7):17, 19-20. PubMed ID: 11363637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substantial cost savings seen in delaying the onset of AIDS.
    AIDS Policy Law; 1999 Oct; 14(20):5. PubMed ID: 11367060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustaining treatment costs: who will pay?
    Zewdie D; De Cock K; Piot P
    AIDS; 2007 Jul; 21 Suppl 4():S1-4. PubMed ID: 17620744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.